275 related articles for article (PubMed ID: 11502066)
21. Allosteric modulation of binding properties between units of chemokine receptor homo- and hetero-oligomers.
Springael JY; Le Minh PN; Urizar E; Costagliola S; Vassart G; Parmentier M
Mol Pharmacol; 2006 May; 69(5):1652-61. PubMed ID: 16467191
[TBL] [Abstract][Full Text] [Related]
22. Molecular characterization of the chemokine receptor CXCR3: evidence for the involvement of distinct extracellular domains in a multi-step model of ligand binding and receptor activation.
Xanthou G; Williams TJ; Pease JE
Eur J Immunol; 2003 Oct; 33(10):2927-36. PubMed ID: 14515277
[TBL] [Abstract][Full Text] [Related]
23. Chemokines and their receptors: orchestrating a fine balance between health and disease.
Sharma M
Crit Rev Biotechnol; 2010 Mar; 30(1):1-22. PubMed ID: 19780653
[TBL] [Abstract][Full Text] [Related]
24. Chemokine receptor dimerization and chemotaxis.
Rodríguez-Frade JM; Muñoz LM; Holgado BL; Mellado M
Methods Mol Biol; 2009; 571():179-98. PubMed ID: 19763967
[TBL] [Abstract][Full Text] [Related]
25. Chemokines induce matrix metalloproteinase-2 through activation of epidermal growth factor receptor in arterial smooth muscle cells.
Kodali R; Hajjou M; Berman AB; Bansal MB; Zhang S; Pan JJ; Schecter AD
Cardiovasc Res; 2006 Feb; 69(3):706-15. PubMed ID: 16343467
[TBL] [Abstract][Full Text] [Related]
26. Right on the spot. Chemokine triggering of integrin-mediated arrest of rolling leukocytes.
Laudanna C; Alon R
Thromb Haemost; 2006 Jan; 95(1):5-11. PubMed ID: 16543955
[TBL] [Abstract][Full Text] [Related]
27. Allosteric inhibitors of chemoattractant receptors: opportunities and pitfalls.
Allegretti M; Bertini R; Bizzarri C; Beccari A; Mantovani A; Locati M
Trends Pharmacol Sci; 2008 Jun; 29(6):280-6. PubMed ID: 18423629
[TBL] [Abstract][Full Text] [Related]
28. Chemokine receptor oligomerization: functional considerations.
Thelen M; Muñoz LM; Rodríguez-Frade JM; Mellado M
Curr Opin Pharmacol; 2010 Feb; 10(1):38-43. PubMed ID: 19828377
[TBL] [Abstract][Full Text] [Related]
29. [Chemokine receptors: their role in human immunodeficiency virus (HIV) pathogenicity and resistance to HIV infections].
Us D
Mikrobiyol Bul; 2003 Jan; 37(1):75-87. PubMed ID: 12838682
[TBL] [Abstract][Full Text] [Related]
30. The role of chemokines in rheumatoid arthritis and osteoarthritis.
Vergunst CE; van de Sande MG; Lebre MC; Tak PP
Scand J Rheumatol; 2005; 34(6):415-25. PubMed ID: 16393761
[TBL] [Abstract][Full Text] [Related]
31. An apparent paradox: chemokine receptor agonists can be used for anti-inflammatory therapy.
Ali S; O'Boyle G; Mellor P; Kirby JA
Mol Immunol; 2007 Mar; 44(7):1477-82. PubMed ID: 17000001
[TBL] [Abstract][Full Text] [Related]
32. Heterophilic chemokine receptor interactions in chemokine signaling and biology.
Kramp BK; Sarabi A; Koenen RR; Weber C
Exp Cell Res; 2011 Mar; 317(5):655-63. PubMed ID: 21146524
[TBL] [Abstract][Full Text] [Related]
33. Role and modulation of G protein-coupled receptor signaling in inflammatory processes.
Lombardi MS; Kavelaars A; Heijnen CJ
Crit Rev Immunol; 2002; 22(2):141-63. PubMed ID: 12433131
[TBL] [Abstract][Full Text] [Related]
34. Chemokines in vascular pathology (review).
Apostolakis S; Papadakis EG; Krambovitis E; Spandidos DA
Int J Mol Med; 2006 May; 17(5):691-701. PubMed ID: 16596249
[TBL] [Abstract][Full Text] [Related]
35. HIV-1 infection and AIDS: consequences for the central nervous system.
Kaul M; Zheng J; Okamoto S; Gendelman HE; Lipton SA
Cell Death Differ; 2005 Aug; 12 Suppl 1():878-92. PubMed ID: 15832177
[TBL] [Abstract][Full Text] [Related]
36. Transmembrane chemokines: versatile 'special agents' in vascular inflammation.
Ludwig A; Weber C
Thromb Haemost; 2007 May; 97(5):694-703. PubMed ID: 17479179
[TBL] [Abstract][Full Text] [Related]
37. Chemokine blockers--therapeutics in the making?
Wells TN; Power CA; Shaw JP; Proudfoot AE
Trends Pharmacol Sci; 2006 Jan; 27(1):41-7. PubMed ID: 16310864
[TBL] [Abstract][Full Text] [Related]
38. SMM-chemokines: a class of unnatural synthetic molecules as chemical probes of chemokine receptor biology and leads for therapeutic development.
Kumar S; Choi WT; Dong CZ; Madani N; Tian S; Liu D; Wang Y; Pesavento J; Wang J; Fan X; Yuan J; Fritzsche WR; An J; Sodroski JG; Richman DD; Huang Z
Chem Biol; 2006 Jan; 13(1):69-79. PubMed ID: 16426973
[TBL] [Abstract][Full Text] [Related]
39. Targeting the chemokine system for multiple sclerosis treatment.
Glabinsk AR; Ransohoff RM
Curr Opin Investig Drugs; 2001 Dec; 2(12):1712-9. PubMed ID: 11892933
[TBL] [Abstract][Full Text] [Related]
40. Virus-encoded chemokine receptors--putative novel antiviral drug targets.
Rosenkilde MM
Neuropharmacology; 2005 Jan; 48(1):1-13. PubMed ID: 15617722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
